rxstat › Drug prices › Ethosuximide
Ethosuximide (Zarontin, Zarontin Syr) price in Canada
No current shortage
Ethosuximide 250 mg capsule costs about $0.26 to $0.28 per capsule on public drug plan price lists across 8 provinces, before the pharmacy's dispensing fee. The brand (Zarontin) lists at $0.58.
Ethosuximide has no current shortage reported in Canada. It has been in shortage before; the history is below.
Price by province
| Strength and form | BC | AB | SK | MB | ON | NB | NS | PE |
|---|---|---|---|---|---|---|---|---|
| 250 mg Capsuleper capsule | $0.28brand $0.58 | $0.26brand $0.53 | $0.26brand $0.54 | $0.26brand $0.54 | $0.26brand $0.53 | $0.26 | $0.26 | $0.26 |
| 250 mg/5ml Syrupper mL | – | $0.077 | $0.078 | – | $0.074 | $0.078 | $0.078 | – |
| Plan coverage | Covered | Covered | Covered | Price list | Covered | Covered | Covered | Price list |
What you'll pay at the pharmacy
These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay. In Ontario, the plan pays only up to the lowest interchangeable price ($0.26 per capsule for 250 mg).
Listed products by province
British Columbia: 3 products
- Mar-Ethosuximide 250 mg Capsule · MAR
- Odan-Ethosuximide 250 mg Capsule · ODN
- Zarontin 250 mg Capsule · SLP
Alberta: 4 products
- Zarontin Syrup 250 mg/5ml Syrup · SLP
- Mar-Ethosuximide 250 mg Capsule · MAR
- Odan-Ethosuximide 250 mg Capsule · ODN
- Zarontin 250 mg Capsule · SLP
Saskatchewan: 4 products
- Zarontin Syrup 250 mg/5ml Syrup · SLP
- Mar-Ethosuximide 250 mg Capsule · MPI
- Odan-Ethosuximide 250 mg Capsule · ODN
- Zarontin 250 mg Capsule · SLP
Manitoba: 3 products
- Mar-Ethosuximide 250 mg Capsule · MAR
- Odan-Ethosuximide 250 mg Capsule · ODN
- Zarontin 250 mg Capsule · SLP
Ontario: 4 products
- Zarontin Syrup 250 mg/5ml Syrup · Searchlight Pharma Inc.
- Mar-Ethosuximide 250 mg Capsule · Marcan Pharmaceuticals Inc.
- Odan-Ethosuximide 250 mg Capsule · Odan Laboratories Ltd.
- Zarontin 250 mg Capsule · Searchlight Pharma Inc.
New Brunswick: 4 products
- Zarontin Syrup 250 mg/5ml Syrup · ERF
- Zarontin 250 mg Capsule · ERF
- Mar-Ethosuximide 250 mg Capsule · MAR
- Odan-Ethosuximide 250 mg Capsule · ODN
Nova Scotia: 4 products
- Zarontin Syrup 250 mg/5ml Syrup · SLP
- Zarontin 250 mg Capsule · SLP
- Mar-Ethosuximide 250 mg Capsule · MAR
- Odan-Ethosuximide 250 mg Capsule · ODN
Prince Edward Island: 3 products
- Zarontin 250 mg Capsule · ERF
- Mar-Ethosuximide 250 mg Capsule · MAR
- Odan-Ethosuximide 250 mg Capsule · ODN
Shortage status
Shortage history
Reports by product
What's happening
There are no active shortage reports for Ethosuximide. Health Canada has 4 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Ethosuximide is classified under “ANTIEPILEPTICS” (ATC N03AD).
Recent changes
- No changes recorded yet.
Common questions
How much does Ethosuximide cost in Canada?
Ethosuximide 250 mg capsule costs about $0.26 to $0.28 per capsule on public drug plan price lists across 8 provinces, before the pharmacy's dispensing fee. The brand (Zarontin) lists at $0.58.
Is Ethosuximide covered by provincial drug plans?
On the public plans' own lists: British Columbia: covered; Alberta: covered; Saskatchewan: covered; Manitoba: price list; Ontario: covered; New Brunswick: covered; Nova Scotia: covered; Prince Edward Island: price list. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.
When will Ethosuximide be back in stock in Canada?
Ethosuximide has no active shortage; supply is normal per Health Canada reports.
Why is Ethosuximide in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Related drugs (antiepileptics)
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.